neutral
Recently
Nephrocare Health opens subscription window as dialysis major targets ₹4,600 crore valuation
Nephrocare Health IPO opened for subscription with a price band of ₹438–460, neutral grey market premium, and strong anchor backing from leading mutual funds and insurance players.
Investor attention is on Nephrocare Health Services Ltd as the company’s IPO opened for subscription on December 10 and will close on December 12. The price band is fixed at ₹438 to ₹460 per share, valuing the company at over ₹4,600 crore. Ahead of the issue, Nephrocare raised ₹260 crore from anchor investors, including SBI Mutual Fund, ICICI Prudential MF, Fidelity, and HDFC Life.